Standard BioTools Inc. (LAB) Stock Overview
Explore Standard BioTools Inc.’s financial performance, market position, analyst ratings, and future outlook.
Standard BioTools Inc. (LAB)
Key Financials
Key Financials
Market Cap
359.5M
P/E Ratio
-3.72
EPS (TTM)
$-0.04
ROE
-0.21%
LAB Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Standard BioTools Inc. (LAB) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 52.22, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.43.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -3.72 and a market capitalization of 359.5M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.